354 related articles for article (PubMed ID: 22987143)
1. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding.
Witt DM; Delate T; Garcia DA; Clark NP; Hylek EM; Ageno W; Dentali F; Crowther MA
Arch Intern Med; 2012 Oct; 172(19):1484-91. PubMed ID: 22987143
[TBL] [Abstract][Full Text] [Related]
2. The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.
Sengupta N; Feuerstein JD; Patwardhan VR; Tapper EB; Ketwaroo GA; Thaker AM; Leffler DA
Am J Gastroenterol; 2015 Feb; 110(2):328-35. PubMed ID: 25512338
[TBL] [Abstract][Full Text] [Related]
3. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation.
Qureshi W; Mittal C; Patsias I; Garikapati K; Kuchipudi A; Cheema G; Elbatta M; Alirhayim Z; Khalid F
Am J Cardiol; 2014 Feb; 113(4):662-8. PubMed ID: 24355310
[TBL] [Abstract][Full Text] [Related]
4. Rebleeding vs Thromboembolism After Hospitalization for Gastrointestinal Bleeding in Patients on Direct Oral Anticoagulants.
Sengupta N; Marshall AL; Jones BA; Ham S; Tapper EB
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1893-1900.e2. PubMed ID: 29775794
[TBL] [Abstract][Full Text] [Related]
5. Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study.
Tapaskar N; Ham SA; Micic D; Sengupta N
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):381-389.e9. PubMed ID: 33227428
[TBL] [Abstract][Full Text] [Related]
6. Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed.
Valanejad SM; Davis KA; Nisly SA
Ann Pharmacother; 2020 Oct; 54(10):975-980. PubMed ID: 32141301
[TBL] [Abstract][Full Text] [Related]
7. Impact of restarting warfarin therapy in renal disease anticoagulated patients with gastrointestinal hemorrhage.
Khalid F; Qureshi W; Qureshi S; Alirhayim Z; Garikapati K; Patsias I
Ren Fail; 2013 Oct; 35(9):1228-35. PubMed ID: 23902367
[TBL] [Abstract][Full Text] [Related]
8. Management of Oral Anticoagulation Therapy After Gastrointestinal Bleeding: Whether to, When to, and How to Restart an Anticoagulation Therapy.
Kido K; Scalese MJ
Ann Pharmacother; 2017 Nov; 51(11):1000-1007. PubMed ID: 28639882
[TBL] [Abstract][Full Text] [Related]
9. Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data.
Hu W; Cai H; Zhang J
Eur J Clin Pharmacol; 2022 Jul; 78(7):1057-1067. PubMed ID: 35296907
[TBL] [Abstract][Full Text] [Related]
10. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.
Witt DM; Clark NP; Martinez K; Schroeder A; Garcia D; Crowther MA; Ageno W; Dentali F; Ye X; Hylek E; Delate T
Thromb Res; 2015 Nov; 136(5):1040-4. PubMed ID: 26454758
[TBL] [Abstract][Full Text] [Related]
11. Resuming Anticoagulation Following Hospitalization for Gastrointestinal Bleeding Is Associated with Reduced Thromboembolic Events and Improved Mortality: Results from a Systematic Review and Meta-Analysis.
Tapaskar N; Pang A; Werner DA; Sengupta N
Dig Dis Sci; 2021 Feb; 66(2):554-566. PubMed ID: 32279174
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcome.
Chen WC; Chen YH; Hsu PI; Tsay FW; Chan HH; Cheng JS; Lai KH
Biomed Res Int; 2014; 2014():463767. PubMed ID: 24987683
[TBL] [Abstract][Full Text] [Related]
13. Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding.
Nagata N; Sakurai T; Moriyasu S; Shimbo T; Okubo H; Watanabe K; Yokoi C; Yanase M; Akiyama J; Uemura N
PLoS One; 2017; 12(9):e0183423. PubMed ID: 28863196
[TBL] [Abstract][Full Text] [Related]
14. Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).
Ashburner JM; Go AS; Reynolds K; Chang Y; Fang MC; Fredman L; Applebaum KM; Singer DE
Am J Cardiol; 2015 Jan; 115(1):40-6. PubMed ID: 25456871
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysis.
Chai-Adisaksopha C; Hillis C; Monreal M; Witt DM; Crowther M
Thromb Haemost; 2015 Oct; 114(4):819-25. PubMed ID: 26018236
[TBL] [Abstract][Full Text] [Related]
16. Optimal antiplatelet therapy for patients after antiplatelet therapy induced gastrointestinal bleeding: timing.
Xiao B; Ye Z; Cheng R; Han Z; Wu S; Wang G; Li Z; Liang T; Zhang S; Huang R
Intern Emerg Med; 2023 Aug; 18(5):1385-1396. PubMed ID: 37195594
[TBL] [Abstract][Full Text] [Related]
17. Resuming anticoagulation after hemorrhage: A practical approach.
Colantino A; Jaffer AK; Brotman DJ
Cleve Clin J Med; 2015 Apr; 82(4):245-56. PubMed ID: 25955459
[TBL] [Abstract][Full Text] [Related]
18. Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding. A risk modelling analysis.
Majeed A; Wallvik N; Eriksson J; Höijer J; Bottai M; Holmström M; Schulman S
Thromb Haemost; 2017 Feb; 117(3):491-499. PubMed ID: 28004062
[TBL] [Abstract][Full Text] [Related]
19. Risk of thromboembolism with short-term interruption of warfarin therapy.
Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin Users.
Carnahan RM; Gagne JJ; Hampp C; Leonard CE; Toh S; Fuller CC; Hennessy S; Hou L; Cocoros NM; Panucci G; Woodworth T; Cosgrove A; Iyer A; Chrischilles EA
Pharmaceut Med; 2019 Feb; 33(1):29-43. PubMed ID: 31933271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
